SRL Diagnostics champions the cause of Preventive Healthcare


-Test to detect stress level, respiratory diseases and lead content in human body-

- Priced at Rs. 4650, available in All Metropolitan Cities-

Chandigarh, July 05, 2016: SRL Diagnostics, the leading diagnostic chain in India, has introduced an innovative Health Champion Package Advanced (HCP advanced) test, to address the growing concern amongst urban population regarding health in the scenario of rising pollution, allergic conditions, stress, food and water contamination etc. 

SRL Diagnostics champions the cause of Preventive Healthcare


HCP Panel is a carefully created package of tests, which not only checks routine health parameters but also comprise of special tests to screen stress level, allergy and lead content in the body. This is another of SRL’s offerings in the realm of preventive healthcare and will be made available in Delhi NCR, Mumbai, Pune, Bangalore, Kolkata and Hyderabad.

Dr. Arnab Roy, Deputy General Manager and senior research scientist, R & D, SRL Ltd said that “There is a significant need for reaching out to people and letting them know about the importance of preventive healthcare. We at SRL are launching this test so as to help people take care of their health armed with the knowledge of the most routine as well as advanced health parameters. This is to encourage more people to undergo healthcare checkups that will further help in early diagnosis and treatment of disease, thereby saving money, resources and lives.”

With the rising incidence of lifestyle and pollution related diseases, preventive healthcare has become an important concept to maintain good health. According to an estimate by World Health Organization in 2011, about 55 million died worldwide, two thirds of them had non communicable diseases like cancer, diabetes,and chronic cardiovascular and lung diseases. There is an increase from the year 2000 as there were 60% of deaths that were attributed to these diseases. 

About SRL Diagnostics

SRL is the largest Diagnostics Company in India having an impressive ‘Reach’, providing superior quality diagnostics services to its customers through a very efficient network of labs and collection points.

 The vision to create SRL diagnostics was driven by the philosophy to provide high quality accurate tests/ outcomes at affordable prices to the masses. SRL is known for high ethical standards synonymous with ‘TRUST’ and each and every constituent of ‘Team SRL’ follows immaculate value system.

SRL Diagnostics has *322 networking laboratories, including *10 Reference Labs, 4 Centers of Excellence, *26 radiology/imaging centers, *39 NBL accredited labs, *4 CAP accredited labs and a footprint spanning over 7272 collection points. The company has large labs in Dubai, Sri Lanka and Nepal, and also about 58 collection points in various countries outside India. SRL Diagnostics is the veritable pioneer of medical diagnostics in India. Established in 1995, the diagnostic center has been imbued with a mission to deliver Gold Standard Diagnostic services, both in the field of Laboratory Medicine and Radiology including high-end Imaging services.

SRL carries out 125,000 tests per day. It is often stated that on the human body about 4000 different types of diagnostics tests could be performed. SRL has over 3800 tests in its repertoire which is the largest menu of tests in India.

SRL has the most Accredited Lab Network in India comprising of 39 NABL accredited labs and 4 CAP accredited labs. SRL continues to revolutionize diagnostic services in India by ushering in the most specialized technologies and innovative services.

Its Research &Innovation division is ISO certified and was the first lab in the Private Sector was recognized by the Government of India‘s Department of Scientific and Industrial Research. SRL’s wide range of tests provides quality diagnostic, prognostic and monitoring services to other path labs, hospitals and patients. It also provides services of testing samples for the Multinational and Indian Pharmaceutical companies/ CROs undertaking Phase III/ IV Clinical Trial work, thereby supporting their international regulatory submissions.